Mergers News
Monday, June 27, 2016
UPDATE 1-Mayne Pharma nears deal for Teva assets -source
June 27 (Reuters) - Australia's Mayne Pharma Group Ltd
on Tuesday said it will acquire U.S. generic products
from Teva Pharmaceuticals for $652 million, helping it
propel into the top 2 in the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment